corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 608

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: Journal Article

Macbeth F, Stephens R.
Marketing clinical trials.
Lancet 1996 Jul 13; 348:(9020):111-2

Keywords:
*analysis United Kingdom drug company sponsored research relationship between researchers, academic institutions and industry clinical trials


Notes:

What rewards can and do clinicians get for the obtaining and transfer of patient data in clinical trials. For most doctors the scale of value probably runs: money>resources>esteem>group membership (being part of an organization)>intellectual curiousity; although publicly doctors may still insist that it is the reverse. At the moment many clinicians fund data managers and/or research nurses by undertaking industry-sponsored investigations. Some may be good studies but many are either disguised marketing exercises or ways of getting data for drug licensing, and they are not often subject to rigorous peer review.

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








...to influence multinational corporations effectively, the efforts of governments will have to be complemented by others, notably the many voluntary organisations that have shown they can effectively represent society’s public-health interests…
A small group known as Healthy Skepticism; formerly the Medical Lobby for Appropriate Marketing) has consistently and insistently drawn the attention of producers to promotional malpractice, calling for (and often securing) correction. These organisations [Healthy Skepticism, Médecins Sans Frontières and Health Action International] are small, but they are capable; they bear malice towards no one, and they are inscrutably honest. If industry is indeed persuaded to face up to its social responsibilities in the coming years it may well be because of these associations and others like them.
- Dukes MN. Accountability of the pharmaceutical industry. Lancet. 2002 Nov 23; 360(9346)1682-4.